NEW YORK, Aug. 23, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, both dates inclusive (the "Class Period"), of the important September...
Related Questions
How might the lawsuit settlement potential affect CAPR's short‑term volatility and price trajectory?
What is the estimated financial exposure from the securities fraud lawsuit and its impact on CAPR's balance sheet and earnings outlook?
Could this litigation risk alter institutional ownership, short‑interest levels, or overall market sentiment toward CAPR compared to its peers?